David Mc Clung Bio Cardia, Inc. (BCDA) insider trading activity

David Mc Clung is Chief Financial Officer of BioCardia, Inc.. Currently has a direct ownership of 76,887 shares of BCDA, which is worth approximately $94,571. The most recent transaction as insider was on Dec 08, 2025, when has been sold 29,339 shares (Common Stock) at a price of $1.37 per share, resulting in proceeds of $40,194. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.9K

60.35% 3M change

156.22% 12M change

Total Value Held $94,571

David McClung Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2025	BUY Payment of exercise price or tax liability	$40,194 $1.37 p/Share	29,339 Added 27.62%	76,887 Common Stock
Dec 08 2025	BUY Grant, award, or other acquisition	$79,838 $1.37 p/Share	58,276 Added 35.43%	106,226 Common Stock
Jun 30 2025	BUY Open market or private purchase	$10,023 $2.08 p/Share	4,819 Added 9.13%	47,950 Common Stock
Apr 23 2025	BUY Open market or private purchase	$24,933 $1.9 p/Share	13,123 Added 23.33%	43,131 Common Stock
Oct 11 2024	SELL Payment of exercise price or tax liability	$30,647 $2.65 p/Share	11,565 Reduced 27.82%	30,008 Common Stock
Oct 11 2024	BUY Grant, award, or other acquisition	$64,111 $2.65 p/Share	24,193 Added 36.79%	41,573 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$24,999 $3.0 p/Share	8,333 Added 32.41%	17,380 Common Stock

Jun 23 2023	BUY Grant, award, or other acquisition	$10,015 $2.34 p/Share	4,280 Added 3.06%	135,724 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$36,596 $1.77 p/Share	20,676 Reduced 13.59%	131,444 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	$104,361 $1.7 p/Share	61,389 Added 28.75%	152,120 Common Stock
Dec 16 2022	BUY Grant, award, or other acquisition	$14,999 $1.68 p/Share	8,928 Added 9.26%	87,446 Common Stock
Oct 10 2022	BUY Open market or private purchase	$4,140 $2.07 p/Share	2,000 Added 2.48%	78,518 Common Stock
May 12 2022	SELL Payment of exercise price or tax liability	$27,234 $1.32 p/Share	20,632 Reduced 21.24%	76,518 Common Stock
Apr 14 2022	BUY Grant, award, or other acquisition	-	50,345 Added 34.13%	97,150 Common Stock
Jun 10 2021	SELL Payment of exercise price or tax liability	$31,642 $4.35 p/Share	7,274 Reduced 13.45%	46,805 Common Stock
Apr 21 2021	SELL Grant, award, or other acquisition	-	21,370 Reduced 28.32%	54,079 Common Stock

David Mc Clung

Chief Financial Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioCardia, Inc.

Track Activities on BCDA

Account